SEC Filings - Bolt Biotherapeutics

Filing date	Description	Form	Filing Group	View
February 4, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001209191-21-007856.pdf 0001209191-21-007856.rtf 0001209191-21-007856.xls View HTML
February 4, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001209191-21-007860.pdf 0001209191-21-007860.rtf 0001209191-21-007860.xls View HTML
February 4, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001209191-21-007902.pdf 0001209191-21-007902.rtf 0001209191-21-007902.xls View HTML
February 4, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001209191-21-007904.pdf 0001209191-21-007904.rtf 0001209191-21-007904.xls View HTML
February 4, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001104659-21-012449.pdf 0001104659-21-012449.rtf 0001104659-21-012449.xls View HTML
February 4, 2021	Registration of up to an additional 20% of securities for any offering registered on an S-1	S-1MEF	Registration Statements	0001193125-21-029328.pdf 0001193125-21-029328.rtf 0001193125-21-029328.xls View HTML
February 4, 2021	EFFECT	EFFECT	Other	9999999995-21-000441.pdf 9999999995-21-000441.rtf 9999999995-21-000441.xls View HTML
February 3, 2021	Amended Registration statement for face-amount certificate companies	S-1/A	Registration Statements	0001193125-21-027469.pdf 0001193125-21-027469.rtf 0001193125-21-027469.xls View HTML
February 2, 2021	Registration of certain classes of securities 12(b) of the Securities Exchange Act	8-A12B	Registration Statements	0001193125-21-025784.pdf 0001193125-21-025784.rtf 0001193125-21-025784.xls View HTML
February 2, 2021	CORRESP	CORRESP	Other	0001193125-21-025787.pdf 0001193125-21-025787.rtf 0001193125-21-025787.xls View HTML

Data provided by Kaleidoscope.